Abstract:Neuroinflammation is an early event of brain injury after subarachnoid hemorrhage (SAH). Whether the macrophage mediators in resolving inflammation 1(MaR1) is involved in SAH pathogenesis is unknown. In this study, 205 male Sprague-Dawley rats were subjected to SAH via endovascular perforation in the experimental and control groups. MaR1 was dosed intranasally at 1 hour after SAH, with LGR6 siRNA and KG-501, GSK-J4 administered to determine the signaling pathway. Neurobehavioral, histological and biochemical data were obtained from the animal groups with designated treatments. The results showed: (i) The leucine-rich repeat containing G protein–coupled receptor 6(LGR6) was decreased after SAH and reached to the lowest level at 24h after SAH. Jumonji d3(JMJD3) protein levels tended to increase and peaked at 24h after SAH. LGR6 and JMJD3 expression were co-localized with microglia. (ii) MaR1 administration mitigated short-term neurological deficits, brain edema and long-term neurobehavioral performance after SAH, and attenuated microglial activation and neutrophil infiltration. (iii) Knockdown of LGR6, inhibition of CREB phosphorylation or JMJD3 activity abolished the anti-neuroinflammatory effect of MaR1 on the expression of CREB, CBP, JMJD3, IRF4, IRF5, IL-1β, IL-6 and IL-10, thus prevented microglial activation and neutrophil infiltration. Together, the results show that MaR1 can activate LGR6 and affect CREB/JMJD3/IRF4 signaling to attenuate neuroinflammation after SAH, pointing to a potential pharmacological utility in this disorder. Graphical abstract Proposed pathway of maresin 1 attenuated neuroinflammation after SAH in rat models. Neuroinflammation was characterized by microglial activation and neutrophils infiltration after SAH. The maresin 1 administration could activate LGR6 receptor, which further activated CREB/JMJD3/IRF4 signaling pathway and decrease the pro-inflammatory cytokines IL-1β,IL-6 while increase the anti-inflammatory cytokine IL-10. Mechanistically, knocked down LGR6 or pharmacological inhibited CREB by KG-501 and JMJD3 by GSK-J4 abolished the neuro-protective effect of maresin 1. Download : Download high-res image (130KB) Download : Download full-size image

Maresin 1 activates LGR6 to alleviate neuroinflammation via the CREB/JMJD3/IRF4 pathway in a rat model of subarachnoid hemorrhage